Literature DB >> 22894902

Human telomerase reverse transcriptase (hTERT) is a target gene of β-catenin in human colorectal tumors.

Stefanie Jaitner1, Jana A Reiche, Achim J Schäffauer, Elke Hiendlmeyer, Hermann Herbst, Thomas Brabletz, Thomas Kirchner, Andreas Jung.   

Abstract

The majority of colorectal cancers (CRCs) are characterized by a dysregulated canonical Wnt-signaling pathway leading to the stabilization and subsequent cellular increase and accumulation of β-catenin. After translocation into the nucleus, it acts as a transcription factor resulting in the expression of β-catenin target genes. These resemble most of the hallmarks of cancer except eternal life. The central mediator of this hallmark is hTERT (human telomerase reverse transcriptase). The hTERT gene is regulated, besides others, by the transcription factor c-Myc and, thus, indirectly via β-catenin as c-Myc is a β-catenin target gene. Interestingly, the expression patterns of hTERT and β-catenin, but not c-Myc are overlapping, probably because c-Myc is not only regulated by β-catenin, but also by many other transcription factors and pathways. Therefore, we argued that hTERT might be a direct target gene of β-catenin. In this study, we show evidence that β-catenin directly regulates the expression of the hTERT gene.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22894902      PMCID: PMC3466531          DOI: 10.4161/cc.21790

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  48 in total

Review 1.  Convergence of Wnt, beta-catenin, and cadherin pathways.

Authors:  W James Nelson; Roel Nusse
Journal:  Science       Date:  2004-03-05       Impact factor: 47.728

2.  Molecular biology. Wnt regulates TERT--putting the horse before the cart.

Authors:  Carol W Greider
Journal:  Science       Date:  2012-06-22       Impact factor: 47.728

3.  Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer.

Authors:  T Zhang; T Otevrel; Z Gao; Z Gao; S M Ehrlich; J Z Fields; B M Boman
Journal:  Cancer Res       Date:  2001-12-15       Impact factor: 12.701

4.  Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells.

Authors:  Udit N Verma; Rama M Surabhi; Aurelia Schmaltieg; Carlos Becerra; Richard B Gaynor
Journal:  Clin Cancer Res       Date:  2003-04       Impact factor: 12.531

5.  The invasion front of human colorectal adenocarcinomas shows co-localization of nuclear beta-catenin, cyclin D1, and p16INK4A and is a region of low proliferation.

Authors:  A Jung; M Schrauder; U Oswald; C Knoll; P Sellberg; R Palmqvist; G Niedobitek; T Brabletz; T Kirchner
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

6.  Regulation of vascular endothelial growth factor by the Wnt and K-ras pathways in colonic neoplasia.

Authors:  X Zhang; J P Gaspard; D C Chung
Journal:  Cancer Res       Date:  2001-08-15       Impact factor: 12.701

7.  Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer.

Authors:  H Ueno; J Murphy; J R Jass; H Mochizuki; I C Talbot
Journal:  Histopathology       Date:  2002-02       Impact factor: 5.087

8.  Beta-catenin up-regulates the expression of the urokinase plasminogen activator in human colorectal tumors.

Authors:  Elke Hiendlmeyer; Susanne Regus; Stella Wassermann; Falk Hlubek; Angela Haynl; Arno Dimmler; Claudia Koch; Claudia Knoll; Moniek van Beest; Ute Reuning; Thomas Brabletz; Thomas Kirchner; Andreas Jung
Journal:  Cancer Res       Date:  2004-02-15       Impact factor: 12.701

9.  Essential role of BCL9-2 in the switch between beta-catenin's adhesive and transcriptional functions.

Authors:  Felix H Brembeck; Thomas Schwarz-Romond; Jeroen Bakkers; Sabine Wilhelm; Matthias Hammerschmidt; Walter Birchmeier
Journal:  Genes Dev       Date:  2004-09-01       Impact factor: 11.361

10.  Transactivation of vimentin by beta-catenin in human breast cancer cells.

Authors:  Christine Gilles; Myriam Polette; Mélanie Mestdagt; Béatrice Nawrocki-Raby; Philippe Ruggeri; Philippe Birembaut; Jean-Michel Foidart
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

View more
  16 in total

1.  α-catenin. A tumor suppressor beyond adherens junctions.

Authors:  Yutong Sun; Jinsong Zhang; Li Ma
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

2.  Telomere protection and TRF2 expression are enhanced by the canonical Wnt signalling pathway.

Authors:  Irmina Diala; Nicole Wagner; Frédérique Magdinier; Marina Shkreli; Maria Sirakov; Serge Bauwens; Caroline Schluth-Bolard; Thomas Simonet; Valérie M Renault; Jing Ye; Abdelnnadir Djerbi; Pascal Pineau; Jinkuk Choi; Steven Artandi; Anne Dejean; Michelina Plateroti; Eric Gilson
Journal:  EMBO Rep       Date:  2013-02-22       Impact factor: 8.807

Review 3.  Sustained proliferation in cancer: Mechanisms and novel therapeutic targets.

Authors:  Mark A Feitelson; Alla Arzumanyan; Rob J Kulathinal; Stacy W Blain; Randall F Holcombe; Jamal Mahajna; Maria Marino; Maria L Martinez-Chantar; Roman Nawroth; Isidro Sanchez-Garcia; Dipali Sharma; Neeraj K Saxena; Neetu Singh; Panagiotis J Vlachostergios; Shanchun Guo; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Alan Bilsland; Amedeo Amedei; Elena Niccolai; Amr Amin; S Salman Ashraf; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Katia Aquilano; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; W Nicol Keith; Somaira Nowsheen
Journal:  Semin Cancer Biol       Date:  2015-04-17       Impact factor: 15.707

4.  Overexpression of a novel regulator of p120 catenin, NLBP, promotes lung adenocarcinoma proliferation.

Authors:  Chang Hee Kim; Hae-Seong Nam; Eun Hee Lee; Seung Hun Han; Hyun Jung Cho; Hee Jin Chung; Nam Soo Lee; Suk Jin Choi; Hojoong Kim; Jeong Seon Ryu; Junhye Kwon; Hongtae Kim
Journal:  Cell Cycle       Date:  2013-06-28       Impact factor: 4.534

Review 5.  Therapeutic targeting of replicative immortality.

Authors:  Paul Yaswen; Karen L MacKenzie; W Nicol Keith; Patricia Hentosh; Francis Rodier; Jiyue Zhu; Gary L Firestone; Ander Matheu; Amancio Carnero; Alan Bilsland; Tabetha Sundin; Kanya Honoki; Hiromasa Fujii; Alexandros G Georgakilas; Amedeo Amedei; Amr Amin; Bill Helferich; Chandra S Boosani; Gunjan Guha; Maria Rosa Ciriolo; Sophie Chen; Sulma I Mohammed; Asfar S Azmi; Dipita Bhakta; Dorota Halicka; Elena Niccolai; Katia Aquilano; S Salman Ashraf; Somaira Nowsheen; Xujuan Yang
Journal:  Semin Cancer Biol       Date:  2015-04-11       Impact factor: 15.707

6.  Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.

Authors:  Lydia Kriegl; Andreas Jung; David Horst; Antonia Rizzani; Rene Jackstadt; Heiko Hermeking; Eike Gallmeier; Alexander L Gerbes; Thomas Kirchner; Burkhard Göke; Enrico N De Toni
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

7.  Hedgehog signaling regulates telomerase reverse transcriptase in human cancer cells.

Authors:  Tapati Mazumdar; Ranjodh Sandhu; Maha Qadan; Jennifer DeVecchio; Victoria Magloire; Akwasi Agyeman; Bibo Li; Janet A Houghton
Journal:  PLoS One       Date:  2013-09-25       Impact factor: 3.240

8.  Epithelial-mesenchymal transition induces endoplasmic-reticulum-stress response in human colorectal tumor cells.

Authors:  Evelyn Zeindl-Eberhart; Lydia Brandl; Sibylle Liebmann; Steffen Ormanns; Silvio K Scheel; Thomas Brabletz; Thomas Kirchner; Andreas Jung
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

9.  Glucose-regulated protein 58 modulates β-catenin protein stability in a cervical adenocarcinoma cell line.

Authors:  Chia-Jung Liao; Tzu-I Wu; Ya-Hui Huang; Ting-Chang Chang; Chyong-Huey Lai; Shih-Ming Jung; Chuen Hsueh; Kwang-Huei Lin
Journal:  BMC Cancer       Date:  2014-08-01       Impact factor: 4.430

10.  MACC1 promotes carcinogenesis of colorectal cancer via β-catenin signaling pathway.

Authors:  Tiantian Zhen; Sujuan Dai; Hui Li; Yang Yang; Lili Kang; Huijuan Shi; Fenfen Zhang; Dongjie Yang; Shirong Cai; Yulong He; Yingjie Liang; Anjia Han
Journal:  Oncotarget       Date:  2014-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.